Table 2.
Patients and tumor characteristics in triple-negative breast cancer cohort
| Parameters | Number | Percentage |
|---|---|---|
| Age (years) | ||
| ≤50 | 51 | 37.8 |
| >50 | 84 | 62.2 |
| Tumor size (mm) | ||
| ≤20 | 44 | 32.6 |
| >20 | 91 | 67.4 |
| Lymph node metastases | ||
| 0 | 82 | 60.7 |
| 1-3 | 28 | 20.7 |
| 3< | 24 | 17.8 |
| Histological grade | ||
| I | 5 | 3.7 |
| II | 29 | 21.5 |
| III | 101 | 74.8 |
| Maspin | ||
| Positive | 116 | 85.9 |
| Negative | 19 | 14.1 |
| EGFR | ||
| Positive | 66 | 48.9 |
| Negative | 69 | 51.1 |
| CK5/6 | ||
| Positive | 80 | 59.3 |
| Negative | 55 | 40.7 |
| CK14 | ||
| Positive | 46 | 34.1 |
| Negative | 89 | 65.9 |
| CD10 | ||
| Positive | 24 | 17.8 |
| Negative | 111 | 82.2 |
| p63 | ||
| Positive | 17 | 12.6 |
| Negative | 118 | 87.4 |